Table of Contents

Gastroparesis, sometimes called delayed gastric emptying or “stomach paralysis,” is a disorder where the movement of food from the stomach into the small intestine is abnormally slow. This isn’t due to a physical blockage but rather nerve or muscle dysfunction in the stomach.

The idea that Ozempic may cause gastroparesis largely comes from its known effect on gastric emptying, which is partly why it works for weight loss. However, reports have surfaced about individuals developing prolonged and severe gastrointestinal symptoms after starting Ozempic, leading to formal diagnoses of gastroparesis.

In this article, we’ll find out whether or not Ozempic causes gastroparesis, what the latest research says, and how to protect yourself if you’re taking Ozempic or considering it.

Key Takeaways

  • There’s no definitive proof that Ozempic directly causes gastroparesis. Still, mounting case reports and studies suggest a possible association, especially when symptoms begin after starting the drug and resolve after stopping it.
  • Gastroparesis can develop for various reasons, including diabetes, neurological issues, and even idiopathic factors.
  • The FDA’s adverse event database contains over 11,000 digestive-related complaints linked to semaglutide, including cases of confirmed delayed gastric emptying.
  • Since diabetes is a known risk factor for gastroparesis, those with longstanding or poorly managed diabetes might already be vulnerable. Ozempic may compound that risk, especially if used without careful monitoring.
  • Ozempic’s prescribing label advises against using it in individuals with known severe gastroparesis.

Does Ozempic Cause Gastroparesis?

Researchers still aren’t sure if Ozempic directly causes the condition.

Gastroparesis has over 90 known causes. In about one-third of cases, doctors don’t even know the exact reason (idiopathic gastroparesis). It’s more likely to affect women, white individuals, and people who often feel full quickly or experience stomach pain.

If you have diabetes, your risk of developing gastroparesis is already higher. In fact, around 30% of gastroparesis cases are related to diabetes, especially if:

    • you’ve had it for more than 10 years
    • have other nerve issues
    • you struggle to keep your blood sugar in check

One study found that diabetic gastroparesis affects around 4.8% of people with type 1 diabetes, 1% of those with type 2, and just 0.1% of people without diabetes. This suggests that if you already have high blood sugar, that could be the underlying reason for stomach paralysis, not necessarily Ozempic.

Can You Take Ozempic If You Have Gastroparesis?

The prescribing information for Ozempic warns that it is not recommended in people with severe gastroparesis. Some people with mild, undiagnosed, or subclinical delayed gastric emptying may still be prescribed Ozempic carefully, often starting at the lowest dose and monitoring symptoms closely. But this should always be done under medical supervision.

  • Dr. Andres Acosta, a gastroenterologist at the Mayo Clinic, says these medications are generally safe and suggests that some of these issues might come from the rapid weight loss itself. He hopes for larger studies to confirm whether these medications directly cause gastroparesis.
  • Dr. Shauna Levy, an obesity medicine doctor, says she hasn’t changed her prescribing habits. In her view, the potential side effects are rare and do not outweigh the health risks of untreated obesity. However, she stresses that these drugs should only be used under medical supervision. If serious side effects show up, the drug should be stopped.

Reports of Gastroparesis Caused by Ozempic

Young man lying on sofa at home grimacing and in pain, holding stomach with hands

Below are case reports of individuals who developed gastroparesis after using semaglutide:

Case 1: Semaglutide triggered gastroparesis even without diabetes

A 53-year-old woman, who didn’t have diabetes, was using semaglutide injections (0.5 mg weekly) for weight loss. After losing about 40 pounds in four months, she started experiencing nausea and stomach pain that lasted for weeks.

She went to the hospital, where tests ruled out serious conditions like blockages or diabetes. When doctors performed an endoscopy, they found undigested food still sitting in her stomach over 24 hours later, strong evidence of delayed gastric emptying.

She stopped taking semaglutide, and within a month, her nausea completely disappeared. Doctors were confident the medication caused her symptoms, so they didn’t need further testing like a gastric emptying scan.

Case 2: Semaglutide triggered gastroparesis in a patient with type 2 diabetes

Another woman, 52 years old with type 2 diabetes, started experiencing pain after meals, bloating, nausea, and a constant feeling of fullness that lasted for seven months. None of the medications she tried helped.

She had a well-controlled diabetes (HbA1c was 5.7%) and no issues on scans, blood flow tests, or endoscopies. But after looking closely at her history, doctors realized her symptoms began just after starting semaglutide.

A gastric emptying study, the gold standard for diagnosing gastroparesis, showed that 24% of food was still in her stomach after four hours, much higher than normal.

She stopped taking semaglutide, and six weeks later, her symptoms were gone. A follow-up scan showed her digestion had returned to normal (6% retention), confirming that the medication likely caused the delayed stomach emptying.

Post-Marketing Reports

Reports to the FDA’s Adverse Event Reporting System (FAERS) have flagged stomach paralysis symptoms among people using GLP-1 receptor agonists like Ozempic, Rybelsus, and Wegovy. There were over 11,000 reports of digestive problems linked to semaglutide across more than 5,000 patients. Common complaints included:

    • Nausea
    • Vomiting
    • Diarrhea
    • Constipation
    • Abdominal pain
    • Pancreatitis

Some of these are classic signs of delayed stomach emptying, and 48 cases were specifically reported as impaired gastric emptying.

Another study showed that people on GLP-1 drugs like Ozempic were 3.67 times more likely to develop gastroparesis than those taking bupropion-naltrexone (Contrave). Specifically, semaglutide was linked to about 10 cases per 1,000 users. For liraglutide (Victoza, Saxenda), it was about 7 cases per 1,000.

How to Prevent Gastroparesis While on Ozempic?

Below are practical strategies that can help support your digestive health and keep you more comfortable while on treatment:

  • Start low and titrate slowly

    Ask your healthcare provider if a longer adjustment period (e.g., 6-8 weeks on the starter dose) might be better for your situation, especially if you’re prone to gastrointestinal sensitivity. This slow titration gives your gastrointestinal system time to adapt. Never rush into a higher dose just to lose weight faster, as it may backfire by triggering intense nausea or vomiting that causes you to stop the drug entirely.

  • Track and report symptoms early

    Mild nausea or appetite changes are common, but symptoms that last more than a few days or worsen over time could signal a bigger issue. Keep a symptom journal or use a notes app to log:
      • When symptoms occur (before/after meals, post-injection, etc.)
      • Severity on a 1-10 scale
      • What you ate that day
      • Any changes in your bowel movements or appetite
    Bring this log to your next doctor’s appointment to help identify patterns.

  • Eat small, frequent meals

    Instead of three large meals, try eating 4-6 smaller meals spaced throughout the day. This prevents your stomach from feeling overwhelmed and can ease early satiety or bloating. Focus on meals that are:
      • Rich in protein (e.g., eggs, Greek yogurt, tofu)
      • Low in fat
      • High in moisture (e.g., broths, stews)
      • Easily digestible (e.g., cooked vegetables, mashed sweet potato, bananas)

  • Stay consistently hydrated

    Aim for at least 8 cups (64 oz) of fluids daily, especially if you’re experiencing reduced appetite or loose stools. Dehydration worsens nausea and can lead to fatigue or electrolyte imbalances. Our tip is to sip water slowly throughout the day instead of gulping it all at once. Add a bit of lemon, cucumber, or a pinch of salt to encourage better fluid retention if needed.

  • Limit high-fat and fried foods

    Fatty meals sit in your stomach longer, which can worsen the drug’s natural effect of delayed gastric emptying. Try to limit:
      • Fried foods
      • Full-fat dairy
      • Fatty cuts of meat
      • Heavy sauces or creamy dressings
    Opt for lean proteins, grilled or steamed foods, and use herbs or vinegar-based dressings to enhance flavor without adding fat.

  • Avoid lying down after eating

    Stay upright for at least 1-2 hours after eating. A gentle walk after meals can also aid digestion. Reclining too soon after a meal can worsen reflux and slow digestion even more. If your stomach is already working more slowly due to the medication, this can lead to discomfort and nausea.

  • Practice mindful eating

    Put your fork down between bites and aim to chew each bite 20-30 times. This simple habit can make a surprising difference in how you feel afterward. Eating too quickly can overload your digestive system. Take your time chewing and avoid distractions while eating to help your body better process meals.

  • Review your medications

    Provide your doctor with a complete list of all medications to identify potential interactions that may affect gastric motility. Some other medications, like opioids, anticholinergics, or even certain antidepressants, can also slow down your stomach. Combining them with Ozempic may increase your risk of developing gastroparesis-like symptoms.

  • Consider anti-nausea strategies

    If nausea becomes uncomfortable but manageable, there are non-drug options that may help:
      • Ginger chews or ginger tea
      • Acupressure wristbands (like Sea-Bands)
      • Peppermint tea or capsules
      • Eating a few plain crackers before meals
    If home remedies aren’t enough, ask your doctor about short-term use of anti-nausea medications like ondansetron or promethazine.

  • Be open to switching medications

    If you’ve tried all the above strategies and still experience severe symptoms, it may be time to reconsider your treatment plan. Some people tolerate other GLP-1 receptor agonists better than Ozempic, or they may benefit from a different class of medication altogether.

Final Thoughts

Most people who take Ozempic won’t develop gastroparesis. What they experience is often temporary nausea, bloating, or early satiety, which are normal effects of a drug designed to slow digestion.

That said, there are real cases of people developing symptoms consistent with gastroparesis while on GLP-1 medications. These cases emphasize the importance of careful monitoring, slow dose escalation, and prompt communication with your provider if something feels off.

Frequently Asked Questions

Mounjaro (tirzepatide) has been linked to delayed stomach emptying, and in rare cases, symptoms resembling gastroparesis. However, a direct causal relationship has not been definitively proven. Most digestive issues reported are temporary and resolve with dose adjustments or stopping the drug.

Yes, several medications can slow stomach emptying or mimic gastroparesis symptoms. These include opioids, anticholinergics, calcium channel blockers, and GLP-1 receptor agonists like Ozempic and Trulicity.

In most cases, slowed gastric emptying from Ozempic is reversible after discontinuing the medication.

Although not officially contraindicated, prescribing information advises against its use in people with severe gastrointestinal disease, including gastroparesis.

Common gastrointestinal side effects of Ozempic include nausea, vomiting, constipation, diarrhea, and bloating. In some individuals, it may cause significantly delayed gastric emptying, leading to symptoms similar to gastroparesis.

Ozempic can slow gastric emptying for up to 5 hours or longer after a meal, particularly during the early weeks of treatment. The effect may lessen over time as your body adjusts to the drug.

Conditions like functional dyspepsia, chronic indigestion, acid reflux, and irritable bowel syndrome (IBS) can mimic the symptoms of gastroparesis. These disorders also cause nausea, bloating, and early fullness, making diagnosis more complex without proper testing.

Related Articles

Sources

Moshiree, B., Potter, M., & Talley, N. J. (2018). Epidemiology and Pathophysiology of Gastroparesis. Gastrointestinal Endoscopy Clinics of North America, 29(1), 1–14. https://doi.org/10.1016/j.giec.2018.08.010

Moshiree, B., Potter, M., & Talley, N. J. (2019). Epidemiology and Pathophysiology of Gastroparesis. Gastrointestinal endoscopy clinics of North America, 29(1), 1–14. https://doi.org/10.1016/j.giec.2018.08.010

Gastroparesis. (2024, October 27). Yale Medicine. https://www.yalemedicine.org/conditions/gastroparesis

Aswath, G. S., Foris, L. A., Ashwath, A. K., & Patel, K. (2023, March 27). Diabetic gastroparesis. StatPearls – NCBI Bookshelf. https://www.ncbi.nlm.nih.gov/books/NBK430794/

Chaudhry, A., Gabriel, B., Noor, J., Jawad, S., & Challa, S. R. (2024). Tendency of semaglutide to induce gastroparesis: a case report. Cureus. https://doi.org/10.7759/cureus.52564

Kalas, M. A., Galura, G. M., & McCallum, R. W. (2021). Medication-Induced Gastroparesis: A Case Report. Journal of investigative medicine high impact case reports, 9, 23247096211051919. https://doi.org/10.1177/23247096211051919

Shu, Y., He, X., Wu, P., Liu, Y., Ding, Y., & Zhang, Q. (2022). Gastrointestinal adverse events associated with semaglutide: A pharmacovigilance study based on FDA adverse event reporting system. Frontiers in Public Health, 10. https://doi.org/10.3389/fpubh.2022.996179

Sodhi, M., Rezaeianzadeh, R., Kezouh, A., & Etminan, M. (2023). Risk of gastrointestinal adverse events associated with Glucagon-Like peptide-1 receptor agonists for weight loss. JAMA, 330(18), 1795. https://doi.org/10.1001/jama.2023.19574

New Ozempic and Wegovy side effects come to light. (2023, October 6). [Video]. NBC News. https://www.nbcnews.com/health/health-news/ozempic-wegovy-linked-severe-medical-conditions-stomach-problems-study-rcna118823

Kalas, M. A., Galura, G. M., & McCallum, R. W. (2021). Medication-Induced Gastroparesis: a case report. Journal of Investigative Medicine High Impact Case Reports, 9. https://doi.org/10.1177/23247096211051919